Name: Trypsin III Inhibitors (IC50, Ki)
Creator: AAT Bioquest
License: https://www.aatbio.com/tou.html

Trypsin III Inhibitors (IC50, Ki)

Structure	Compound Name	Standard Type	Standard Values (in nM)
	1-[n-(Naphthalen-2-Ylsulfonyl)glycyl-4-Carbamimidoyl-D-Phenylalanyl]piperidine	Ki	690.0 ^[1]
	2-[(1R,4S,7S,13S,19S,22S,25S,28S,31R,34S,40S,43S,49S)-25-(4-Aminobutyl)-49-benzyl-4,19-bis[(2S)-butan-2-yl]-34-[3-(diaminomethylideneamino)propyl]-28-[(1R)-1-hydroxyethyl]-22-(hydroxymethyl)-3,6,12,18,21,24,27,30,33,36,39,42,48,51-tetradecaoxo-53,54-dithia-2,5,11,17,20,23,26,29,32,35,38,41,47,50-tetradecazapentacyclo[29.20.4.07,11.013,17.043,47]pentapentacontan-40-yl]acetic acid	Ki	4960.0 ^[1]
	4-Aminobenzamidine dihydrochloride	Ki	13100.0 ^[1]
	2-[(1R,4S,7S,13S,19S,22S,25S,28S,31R,34S,40S,43R,49S)-25-(4-Aminobutyl)-49-benzyl-4,19-bis[(2S)-butan-2-yl]-34-[3-(diaminomethylideneamino)propyl]-28-[(1R)-1-hydroxyethyl]-22-(hydroxymethyl)-3,6,12,18,21,24,27,30,33,36,39,42,48,51-tetradecaoxo-53,54-dithia-2,5,11,17,20,23,26,29,32,35,38,41,47,50-tetradecazapentacyclo[29.20.4.07,11.013,17.043,47]pentapentacontan-40-yl]acetic acid	Ki	1.06 ^[1]
	2-[(1R,4S,7S,13S,19S,22S,25S,28S,31R,34S,40S,43S,49S)-49-Benzyl-4-[(2S)-butan-2-yl]-25,34-bis(3-carbamimidamidopropyl)-28-[(1R)-1-hydroxyethyl]-22-(hydroxymethyl)-19-(naphthalen-2-ylmethyl)-3,6,12,18,21,24,27,30,33,36,39,42,48,51-tetradecaoxo-53,54-dithia-2,5,11,17,20,23,26,29,32,35,38,41,47,50-tetradecazapentacyclo[29.20.4.07,11.013,17.043,47]pentapentacontan-40-yl]acetic acid	Ki	38.0 ^[1]
Rows per page: 1–5 of 23

References

This online resource may be cited as follows

MLA	"Quest Database™ Trypsin III Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 20 Jan. 2026, https://www.aatbio.com/data-sets/trypsin-iii-inhibitors-ic50-ki.
APA	AAT Bioquest, Inc. (2026, January 20). Quest Database™ Trypsin III Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/trypsin-iii-inhibitors-ic50-ki.
BibTeX	EndNote	RefMan